What if there was a way to harness all this data we’re collecting and turn it into a strategic advantage for our clinical trials? Indeed, Biorasi’s data sciences team has found a way. Methods beyond risk-based monitoring are required for a more comprehensive yet efficient clinical trial monitoring approach.